Extendicare Inc.
Extendicare Inc. (EXE.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
EXE.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsExtendicare Inc. trailing twelve-month (TTM) revenue is $1.75B, an increase of 13.25% year-over-year from $1.66B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.66B | +$0.19B | +13.25% |
| 2024-12-31 | $1.47B | +$0.16B | +12.36% |
| 2023-12-31 | $1.30B | +$0.08B | +6.83% |
| 2022-12-31 | $1.22B | +$0.05B | +4.68% |
| 2021-12-31 | $1.17B | +$0.06B | +5.75% |
| 2020-12-31 | $1.10B | -$0.03B | -2.51% |
| 2019-12-31 | $1.13B | +$0.01B | +1.07% |
| 2018-12-31 | $1.12B | +$0.02B | +2.07% |
| 2017-12-31 | $1.10B | +$0.04B | +3.45% |
| 2016-12-31 | $1.06B | +$0.12B | +12.45% |
Compare revenue vs peers
Medical - Care FacilitiesCompare EXE.TO revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Extendicare Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Extendicare Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Extendicare Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
EXE.TO revenue · 4 questionsEXE.TO's trailing twelve-month (TTM) revenue is $1.75B. That is an increase of 13.25% year-over-year from $1.66B in FY2025.
▸ Source: FMP · Extendicare Inc. SEC filings · GAAP · Extendicare Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026